I agree with the statement above that the clinical trials may be conducted depending on partially where the disease may be more prominent but the secondary is also the cost. This cost can be whether the company is directly managing the different sites or acts as a sponsor and has a CRO that performs the entire process. In addition, depending on what regulatory body the company is trying to get approval, there may be specific requirements to get the device tested to affect the certain population.